- Home
- KAPA vs DALN Comparison
KAPA vs DALN Comparison
Compare KAPA & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAPA
- DALN
- Stock Information
- Founded
- KAPA 2013
- DALN 1954
- Country
- KAPA United States
- DALN United States
- Employees
- KAPA N/A
- DALN N/A
- Industry
- KAPA
- DALN Newspapers/Magazines
- Sector
- KAPA
- DALN Consumer Discretionary
- Exchange
- KAPA NYSE
- DALN Nasdaq
- Market Cap
- KAPA 21.3M
- DALN 22.1M
- IPO Year
- KAPA 2024
- DALN 2008
- Fundamental
- Price
- KAPA $1.45
- DALN $4.69
- Analyst Decision
- KAPA Strong Buy
- DALN
- Analyst Count
- KAPA 1
- DALN 0
- Target Price
- KAPA $9.00
- DALN N/A
- AVG Volume (30 Days)
- KAPA 203.7K
- DALN 16.6K
- Earning Date
- KAPA 11-23-2024
- DALN 11-01-2024
- Dividend Yield
- KAPA N/A
- DALN 13.65%
- EPS Growth
- KAPA N/A
- DALN N/A
- EPS
- KAPA N/A
- DALN N/A
- Revenue
- KAPA N/A
- DALN $131,645,000.00
- Revenue This Year
- KAPA N/A
- DALN N/A
- Revenue Next Year
- KAPA N/A
- DALN N/A
- P/E Ratio
- KAPA N/A
- DALN N/A
- Revenue Growth
- KAPA N/A
- DALN N/A
- 52 Week Low
- KAPA $1.22
- DALN $2.98
- 52 Week High
- KAPA $4.00
- DALN $4.80
- Technical
- Relative Strength Index (RSI)
- KAPA N/A
- DALN 64.60
- Support Level
- KAPA N/A
- DALN $4.28
- Resistance Level
- KAPA N/A
- DALN $4.80
- Average True Range (ATR)
- KAPA 0.00
- DALN 0.17
- MACD
- KAPA 0.00
- DALN 0.05
- Stochastic Oscillator
- KAPA 0.00
- DALN 85.86
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.